Guangdong Taienkang Pharmaceutical Co., Ltd.

¥20.01As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301263Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 9.35%
Div yield 0.21%
ROE 0.64%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.29
PE TTM 343.0
TSR TTM (25.09%)
Mkt cap ¥10.03B
ROIC (0.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
12.08%
(65.64%)
Sell 1|12|5|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.33
0.37
0.40
0.38
7.01%
14.68%
23.14%
18.59%
Revenue¥M
460.7
447.7
445.4
448.9
2.74%
0.79%
1.50%
0.61%
Peers (US$1.503B)
Cap (US$)
PE
1.515B
13.84x
Capital
TTM
5Y
10Y
Leveragex
1.071
(0.224)
(0.194)
EBIT/Intx
0.394
0.549
0.481
Own earn%
(3.42)
161.09
137.92
Sh yield%
27.84
36.39
36.69
Owners
Insiders/Inst%
0.51
66.32
Short interest%
4.92
SBC / revenue%
2.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
20–26
$1 testx
0.0
Incr. ROIC%
37